Your browser doesn't support javascript.
loading
EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients.
Thijs, Judith L; Drylewicz, Julia; Fiechter, Renée; Strickland, Ian; Sleeman, Matthew A; Herath, Athula; May, Richard D; Bruijnzeel-Koomen, Catharina A F M; Knol, Edward F; Giovannone, Barbara; de Bruin-Weller, Marjolein S; Nierkens, Stefan; Hijnen, Dirk Jan.
Afiliación
  • Thijs JL; Department of Dermatology and Allergology, University Medical Center, Utrecht, The Netherlands; Laboratory of Translational Immunology, Utrecht, The Netherlands.
  • Drylewicz J; Laboratory of Translational Immunology, Utrecht, The Netherlands.
  • Fiechter R; Department of Dermatology and Allergology, University Medical Center, Utrecht, The Netherlands; Laboratory of Translational Immunology, Utrecht, The Netherlands.
  • Strickland I; MedImmune, Granta Park, Cambridge, United Kingdom.
  • Sleeman MA; MedImmune, Granta Park, Cambridge, United Kingdom.
  • Herath A; MedImmune, Granta Park, Cambridge, United Kingdom.
  • May RD; MedImmune, Granta Park, Cambridge, United Kingdom.
  • Bruijnzeel-Koomen CAFM; Department of Dermatology and Allergology, University Medical Center, Utrecht, The Netherlands.
  • Knol EF; Department of Dermatology and Allergology, University Medical Center, Utrecht, The Netherlands; Laboratory of Translational Immunology, Utrecht, The Netherlands.
  • Giovannone B; Department of Dermatology and Allergology, University Medical Center, Utrecht, The Netherlands.
  • de Bruin-Weller MS; Department of Dermatology and Allergology, University Medical Center, Utrecht, The Netherlands.
  • Nierkens S; Laboratory of Translational Immunology, Utrecht, The Netherlands; U-DAIR, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Hijnen DJ; Department of Dermatology and Allergology, University Medical Center, Utrecht, The Netherlands; Laboratory of Translational Immunology, Utrecht, The Netherlands. Electronic address: dirkjanhijnen@gmail.com.
J Allergy Clin Immunol ; 140(6): 1703-1705, 2017 12.
Article en En | MEDLINE | ID: mdl-28823810
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Índice de Severidad de la Enfermedad / Receptores de Interleucina-2 / Interleucinas / Dermatitis Atópica / Quimiocina CCL17 Aspecto: Patient_preference Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Índice de Severidad de la Enfermedad / Receptores de Interleucina-2 / Interleucinas / Dermatitis Atópica / Quimiocina CCL17 Aspecto: Patient_preference Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos